Cardiology

Ezetimibe not tied to higher cancer risk, mortality

(HealthDay)—Treatment with the lipid-lowering therapy ezetimibe/simvastatin is not associated with an increased risk of developing cancer or an increased risk of dying from cancer, according to research published in the ...

Overweight & Obesity

Simvastatin blunts benefits of exercise in overweight, obese

(HealthDay)—Cholesterol-lowering therapy with simvastatin reduces the physiological responses to aerobic exercise training in overweight or obese adults who are at increased risk for metabolic syndrome, according to research ...

Diabetes

Initiating statins linked to increased risk of T2DM

(HealthDay)—Initiating statin therapy is associated with an increased risk of type 2 diabetes, which is not explained by differential survival, according to a study published in the May issue of Diabetes Care.

page 2 from 4